AlertWatch

AlertWatch is a clinically proven FDA-cleared patient monitoring solution that provides a centralized triage dashboard to aggregate data from various sources, offering clinicians a comprehensive view of a patient's vital sign trends. The patented system simultaneously analyzes multi-parameter data from inpatient vitals, electronic medical records (EMRs), laboratory systems, and BioIntelliSense's wearable devices. It utilizes advanced analytics and algorithmic alerting to generate actionable insights, enabling proactive clinical interventions and personalized patient care across different healthcare settings.

Over the past decade, AlertWatch has obtained four FDA 510(k) clearances for its specialized offerings designed for operating rooms, intensive care units, and labor and delivery units. The system has assisted in over one million surgical procedures and 25,000 births. A study published in The Journal of Anesthesiology in 2018, involving 27,000 patients over six years, demonstrated that the AlertWatch operating room solution was associated with a one-day reduction in post-operative length of stay and a USD 3,603 reduction in encounter charges when compared to non-users.

In October 2022, BioIntelliSense, a continuous health monitoring and clinical intelligence company, acquired AlertWatch. This acquisition was part of BioIntelliSense's strategic partnership with Medtronic, allowing Medtronic's Patient Monitoring business to distribute AlertWatch to hospitals throughout the US as a new offering in its HealthCast portfolio.